Literature DB >> 11170281

Human hepatocellular carcinoma is characterized by a highly consistent pattern of genomic imbalances, including frequent loss of 16q23.1-24.1.

B R Balsara1, J Pei, A De Rienzo, D Simon, A Tosolini, Y Y Lu, F M Shen, X Fan, W Y Lin, K H Buetow, W T London, J R Testa.   

Abstract

Comparative genomic hybridization (CGH) analysis was used to identify chromosomal imbalances in 52 human primary hepatocellular carcinomas (HCCs). The most prominent changes were gains of part or all of chromosome arms 8q (83% of cases) and 1q (73%) and loss of 16q (63%). Other commonly overrepresented sites were 5p, 7q, and Xq. Recurrent sites of DNA sequence amplification included 8q23--24 (five cases) and 11q13--14 (four cases). Other frequently underrepresented sites were 4q, 8p, 16p, and 17p. Taken collectively, these findings and data from other CGH studies of HCCs define a subset of chromosome segments that are consistently over- or underrepresented and highlight sites of putative oncogenes and tumor suppressor genes, respectively, involved in hepatocellular oncogenesis. Loss of heterozygosity analysis with a panel of polymorphic microsatellite markers distributed along 16q defined a minimal region of chromosomal loss at 16q23.1--24.1, suggesting that this region harbors a tumor suppressor gene whose loss/inactivation may contribute to the pathogenesis of many HCCs. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2001        PMID: 11170281     DOI: 10.1002/1098-2264(2000)9999:9999<::aid-gcc1083>3.0.co;2-m

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  16 in total

Review 1.  Chromosome 1q21 amplification and oncogenes in hepatocellular carcinoma.

Authors:  Leilei Chen; Tim Hon Man Chan; Xin-yuan Guan
Journal:  Acta Pharmacol Sin       Date:  2010-08-02       Impact factor: 6.150

2.  Recurrent alterations of the WW domain containing oxidoreductase gene spanning the common fragile site FRA16D in multiple myeloma and monoclonal gammopathy of undetermined significance.

Authors:  Hiroshi Handa; Yoshiko Sasaki; Hikaru Hattori; Lobna Alkebsi; Tetsuhiro Kasamatsu; Takayuki Saitoh; Takeki Mitsui; Akihiko Yokohama; Norifumi Tsukamoto; Morio Matsumoto; Hirokazu Murakami
Journal:  Oncol Lett       Date:  2017-07-26       Impact factor: 2.967

3.  Investigation of chromosomal aberrations in Egyptian hepatocellular carcinoma patients by fluorescence in situ hybridization.

Authors:  Magdy S Aly; Abeer A Bahnassy; Zekri N Abdel-Rahman
Journal:  Indian J Hum Genet       Date:  2010-05

4.  Chromosomal abnormalities determined by comparative genomic hybridization are helpful in the diagnosis of atypical hepatocellular neoplasms.

Authors:  Sanjay Kakar; Xin Chen; Coral Ho; Lawrence J Burgart; Oyedele Adeyi; Dhanpat Jain; Viabhav Sahai; Linda D Ferrell
Journal:  Histopathology       Date:  2009-08       Impact factor: 5.087

5.  The JNK inhibitor SP600129 enhances apoptosis of HCC cells induced by the tumor suppressor WWOX.

Authors:  Ileana Aderca; Catherine D Moser; Manivannan Veerasamy; Ahmad H Bani-Hani; Ruben Bonilla-Guerrero; Kadra Ahmed; Abdirashid Shire; Sophie C Cazanave; Damian P Montoya; Teresa A Mettler; Lawrence J Burgart; David M Nagorney; Stephen N Thibodeau; Julie M Cunningham; Jin-Ping Lai; Lewis R Roberts
Journal:  J Hepatol       Date:  2008-06-09       Impact factor: 25.083

6.  Hepatocellular carcinoma arising in adenoma: similar immunohistochemical and cytogenetic features in adenoma and hepatocellular carcinoma portions of the tumor.

Authors:  Sanjay Kakar; James P Grenert; Valerie Paradis; Nicolas Pote; Shriram Jakate; Linda D Ferrell
Journal:  Mod Pathol       Date:  2014-04-18       Impact factor: 7.842

7.  Amplification and overexpression of the EMS 1 oncogene, a possible prognostic marker, in human hepatocellular carcinoma.

Authors:  Bao-Zhu Yuan; Xiaoling Zhou; Drazen B Zimonjic; Marian E Durkin; Nicholas C Popescu
Journal:  J Mol Diagn       Date:  2003-02       Impact factor: 5.568

8.  Atypical hepatocellular adenoma-like neoplasms with β-catenin activation show cytogenetic alterations similar to well-differentiated hepatocellular carcinomas.

Authors:  Kimberley J Evason; James P Grenert; Linda D Ferrell; Sanjay Kakar
Journal:  Hum Pathol       Date:  2012-10-16       Impact factor: 3.466

9.  Epigenetic identification of ADAMTS18 as a novel 16q23.1 tumor suppressor frequently silenced in esophageal, nasopharyngeal and multiple other carcinomas.

Authors:  H Jin; X Wang; J Ying; A H Y Wong; H Li; K Y Lee; G Srivastava; A T C Chan; W Yeo; B B Y Ma; T C Putti; M L Lung; Z-Y Shen; L-Y Xu; C Langford; Q Tao
Journal:  Oncogene       Date:  2007-06-04       Impact factor: 9.867

10.  Genetic variation and its role in malignancy.

Authors:  Bente A Talseth-Palmer; Rodney J Scott
Journal:  Int J Biomed Sci       Date:  2011-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.